ACTIVE

IBIS PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

561,9 k €

-18.0% YoY

Revenue

16,9 M €

-5.3% YoY

Equity

4 M €

+16.6% YoY

Workforce

5,8 ETP

-3.3% YoY

What does IBIS PHARMA do?

IBIS PHARMA is a Public limited company incorporated in 1992. Its registered office is in Schaerbeek. It employs on average 5,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0448.505.234

Incorporation

27/10/1992

Legal form

Public limited company

Registered office

Boulevard Général Wahis 20a
1030 Schaerbeek · BruxellesSee on map

Contributed capital

174 368,05 €

Latest accounts

31/12/2025

Average workforce

5,8 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	16,9 M €	-5.3%	17,9 M €	+11.9%	16 M €		–		–		–		–		–		–		–		8,8 M €	+25.0%	7 M €	+14.3%	6,1 M €	-0.3%	6,2 M €	+17.1%	5,3 M €		–		–		–		–		–
EBITDA	798 k €	-15.9%	949,3 k €	+51.1%	628,3 k €	-28.2%	875,3 k €	-6.9%	940,6 k €	+18.1%	796,5 k €	-15.3%	940,7 k €	+53.2%	614,1 k €	-20.6%	773,1 k €	+12.0%	690,4 k €	+14.8%	601,3 k €	+31.0%	458,8 k €	-0.6%	461,7 k €	-0.6%	464,3 k €	+8.3%	428,7 k €	+0.0%	428,7 k €	+38.2%	310,1 k €	-19.5%	385,3 k €	+32.0%	291,9 k €	+13.2%	257,8 k €
Operating result	775,1 k €	-15.2%	914,4 k €	+51.5%	603,4 k €	-29.1%	850,6 k €	-6.8%	912,4 k €	+20.1%	759,8 k €	-16.5%	909,5 k €	+55.6%	584,4 k €	-20.3%	733 k €	+12.5%	651,3 k €	+14.3%	569,8 k €	+32.6%	429,6 k €	-3.9%	447 k €	+0.0%	447 k €	+8.7%	411,2 k €	+0.2%	410,3 k €	+40.5%	292 k €	-20.7%	368,2 k €	+32.3%	278,3 k €	+14.0%	244,2 k €
Net result	561,9 k €	-18.0%	684,9 k €	+55.4%	440,8 k €	-34.8%	676,1 k €	-3.4%	699,9 k €	+25.1%	559,5 k €	-13.8%	649,1 k €	+44.3%	449,7 k €	-2.2%	459,7 k €	+2.4%	448,8 k €	+12.5%	399,1 k €	+26.0%	316,9 k €	+2.2%	310,1 k €	-14.5%	362,8 k €	+18.3%	306,7 k €	+0.2%	306 k €	+33.7%	228,9 k €	-21.5%	291,6 k €	+33.2%	218,8 k €	+15.0%	190,3 k €
Balance sheet
Equity	4 M €	+16.6%	3,4 M €	-0.4%	3,4 M €	+4.3%	3,3 M €	+26.1%	2,6 M €	-7.2%	2,8 M €	-13.6%	3,2 M €	+4.8%	3,1 M €	+17.1%	2,6 M €	-1.5%	2,7 M €	-17.1%	3,2 M €	+14.1%	2,8 M €	+12.7%	2,5 M €	+14.1%	2,2 M €	+19.8%	1,8 M €	+20.1%	1,5 M €	-13.9%	1,8 M €	+14.8%	1,5 M €	+23.3%	1,3 M €	+21.2%	1 M €
Total assets	5,9 M €	-10.2%	6,6 M €	+13.0%	5,8 M €	-7.3%	6,3 M €	+29.8%	4,8 M €	+27.3%	3,8 M €	-24.5%	5 M €	+36.8%	3,7 M €	-8.3%	4 M €	+4.5%	3,8 M €	-17.7%	4,6 M €	-12.4%	5,3 M €	+82.4%	2,9 M €	+16.4%	2,5 M €	+24.6%	2 M €	-3.9%	2,1 M €	-2.7%	2,1 M €	+20.2%	1,8 M €	+22.1%	1,5 M €	+8.6%	1,3 M €
Cash	1,6 M €	+71.1%	945 k €	-18.2%	1,2 M €	+63.6%	705,9 k €	-58.7%	1,7 M €	+161%	654,5 k €	+97.8%	330,9 k €	-50.5%	668,1 k €	+29.8%	514,7 k €	-3.9%	535,5 k €	+52.1%	352,1 k €	-21.2%	446,7 k €	+60.8%	277,9 k €	-75.3%	1,1 M €	+56.0%	720,8 k €	-10.3%	803,7 k €	+299%	201,5 k €	+82.4%	110,5 k €	-37.1%	175,7 k €	+7.9%	162,8 k €
Debts	1,8 M €	-42.7%	3,1 M €	+38.2%	2,2 M €	-17.7%	2,7 M €	+33.0%	2 M €	+141%	847,9 k €	-50.8%	1,7 M €	+199%	576,6 k €	-52.0%	1,2 M €	+10.9%	1,1 M €	-23.0%	1,4 M €	-38.6%	2,3 M €	+474%	399,4 k €	+33.2%	299,9 k €	+74.2%	172,2 k €	-68.8%	551,4 k €	+51.5%	364,1 k €	+63.7%	222,4 k €	+27.8%	173,9 k €	-35.7%	270,5 k €
Other
Workforce	5,8 ETP	-3.3%	6,0 ETP	0.0%	6,0 ETP	+7.1%	5,6 ETP	+12.0%	5,0 ETP	0.0%	5,0 ETP	0.0%	5,0 ETP	0.0%	5,0 ETP	+25.0%	4,0 ETP	0.0%	4,0 ETP	-7.0%	4,3 ETP	+7.5%	4,0 ETP	+21.2%	3,3 ETP	+37.5%	2,4 ETP	+20.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	-4.8%	2,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 3 ended

Active mandates

Jean Pierre DELEGLISE

Director

Active

PHILIPPE MARECHAL

Managing director

Active

SERGE DASSAS

Director

Active

Ended mandates

Jean Pierre DELEGLISE

Director · since 22 janvier 2010 · until 03 mai 2016

Ended

Philippe MARECHAL

Managing director · since 05 mai 2009 · until 05 mai 2015

Ended

Serge DASSAS

Director · since 05 mai 2009 · until 05 mai 2015

Ended

At this address

Other companies at this address

Company	CBE no.
ALPHA PRIME● Active	0448.698.244
LONDON DIGITAL BELGIUM● Active	0464.465.890
NYOTA INVEST● Active	0502.895.411

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/07/2026	27/05/2025	24/07/2024	22/05/2023	04/07/2022	09/06/2021
General meeting	05/05/2026	06/05/2025	07/05/2024	02/05/2023	03/05/2022	04/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	05/05/2026	13/07/2026	French	PDF
Full model	31/12/2024	06/05/2025	27/05/2025	French	PDF
Full model	31/12/2023	07/05/2024	24/07/2024	French	PDF
Abridged model	31/12/2022	02/05/2023	22/05/2023	French	PDF
Abridged model	31/12/2021	03/05/2022	04/07/2022	French	PDF
Abridged model	31/12/2020	04/05/2021	09/06/2021	French	PDF
Abridged model	31/12/2019	05/05/2020	09/07/2020	French	PDF
Abridged model	31/12/2018	07/05/2019	27/08/2019	French	PDF
Abridged model	31/12/2017	02/05/2018	27/07/2018	French	PDF
Abridged model	31/12/2016	02/05/2017	28/08/2017	French	PDF
Full model	31/12/2015	03/05/2016	13/07/2016	French	PDF
Full model	31/12/2014	05/05/2015	30/07/2015	French	PDF
Full model	31/12/2013	06/05/2014	21/08/2014	French	PDF
Full model	31/12/2012	01/05/2013	22/08/2013	French	PDF
Full model	31/12/2011	02/05/2012	31/08/2012	French	PDF
Abridged model	31/12/2010	03/05/2011	23/08/2011	French	PDF
Abridged model	31/12/2009	04/05/2010	26/08/2010	French	PDF
Abridged model	31/12/2008	05/05/2009	18/08/2009	French	PDF
Abridged model	31/12/2007	06/05/2008	29/07/2008	French	PDF
Abridged model	31/12/2006	07/05/2007	22/08/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 3 ended

Active mandates

Jean Pierre DELEGLISE

Director

Active

PHILIPPE MARECHAL

Managing director

Active

SERGE DASSAS

Director

Active

Ended mandates

Jean Pierre DELEGLISE

Director · since 22 janvier 2010 · until 03 mai 2016

Ended

Philippe MARECHAL

Managing director · since 05 mai 2009 · until 05 mai 2015

Ended

Serge DASSAS

Director · since 05 mai 2009 · until 05 mai 2015

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/06/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates22/09/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Court decision12/02/2024
RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
PDF
Mandates14/07/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates30/07/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates14/07/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates09/02/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates16/12/2009
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025561,9 k €↓
2024
Annual accounts 2024684,9 k €↑
2023
Annual accounts 2023440,8 k €↓
2022
Annual accounts 2022676,1 k €↓
2021
Annual accounts 2021699,9 k €↑
2020
Annual accounts 2020559,5 k €↓
2019
Annual accounts 2019649,1 k €↑
2018
Annual accounts 2018449,7 k €↓
2017
Annual accounts 2017459,7 k €↑
2016
Annual accounts 2016448,8 k €↑
2015
Annual accounts 2015399,1 k €↑
2014
Annual accounts 2014316,9 k €↑
2013
Annual accounts 2013310,1 k €↓
2012
Annual accounts 2012362,8 k €↑
2011
Annual accounts 2011306,7 k €↑
2010
Annual accounts 2010306 k €↑
2009
Annual accounts 2009228,9 k €↓
2008
Annual accounts 2008291,6 k €↑
2007
Annual accounts 2007218,8 k €↑
2006
Annual accounts 2006190,3 k €
27/10/1992
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

IBIS PHARMA

Overview

What does IBIS PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline